Editas Medicine (EDIT) Return on Equity (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Return on Equity data on file, last reported at 0.07% in Q4 2025.

• Return on Equity for Q4 2025 came in at 0.07%, down 6.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.07% (down 6.0% YoY), and the FY2024 annual result was 0.01%, down 1.0% from the prior year.
• Return on Equity advanced to 0.07% in Q4 2025 per EDIT's latest filing, from 0.12% in the prior quarter.
• Over five years, Return on Equity peaked at 0.0% in Q2 2021 and troughed at 0.12% in Q3 2025.
• A 5-year average of 0.02% and a median of 0.01% in 2022 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2021 and 2025: Return on Equity changed 0 bps in 2021, then declined 11 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then plunged by 68 bps to 0.01% in 2022, then advanced by 25 bps to 0.0% in 2023, then sank by 258 bps to 0.02% in 2024, then plunged by 388 bps to 0.07% in 2025.
• Business Quant data shows EDIT's Return on Equity at 0.07% in Q4 2025, 0.12% in Q3 2025, and 0.06% in Q2 2025.